Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainSH3_2

MYO15B PIK3R1 SH3D19

6.03e-0486363IPR011511
DomainSH3_2

MYO15B PIK3R1 SH3D19

6.03e-0486363PF07653
DomainMYOSIN_MOTOR

MYO15B MYO9A

2.43e-0338362PS51456
DomainMyosin_head

MYO15B MYO9A

2.43e-0338362PF00063
DomainMyosin_head_motor_dom

MYO15B MYO9A

2.43e-0338362IPR001609
DomainMYSc

MYO15B MYO9A

2.43e-0338362SM00242
DomainRhoGAP

MYO9A PIK3R1

6.35e-0362362SM00324
DomainRhoGAP

MYO9A PIK3R1

6.55e-0363362PF00620
DomainRHOGAP

MYO9A PIK3R1

6.76e-0364362PS50238
DomainRhoGAP_dom

MYO9A PIK3R1

6.76e-0364362IPR000198
Domain-

MYO9A PIK3R1

6.76e-03643621.10.555.10
DomainSH3

MYO15B PIK3R1 SH3D19

8.22e-03216363PS50002
DomainSH3

MYO15B PIK3R1 SH3D19

8.22e-03216363SM00326
DomainSH3_domain

MYO15B PIK3R1 SH3D19

8.65e-03220363IPR001452
DomainRho_GTPase_activation_prot

MYO9A PIK3R1

1.25e-0288362IPR008936
DomainIQ_motif_EF-hand-BS

MYO15B MYO9A

1.30e-0290362IPR000048
DomainIQ

MYO15B MYO9A

1.38e-0293362PS50096
PathwayREACTOME_RHOV_GTPASE_CYCLE

CCP110 MYO9A PIK3R1

5.80e-0537293M41819
PathwayREACTOME_RHOV_GTPASE_CYCLE

CCP110 MYO9A PIK3R1

5.80e-0537293MM15610
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

BDP1 CHD9 KATNIP ZFHX3 ZNF236 NFAT5 MYO9A ADCY3 RALGPS1 SBF2

2.43e-061489371028611215
Pubmed

Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1- and phosphatidylinositol 3-kinase-dependent mechanisms.

PIK3R1 CD36

3.30e-06337219640849
Pubmed

mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.

SMC3 MYO9A PUF60 SH3D19

3.64e-069837434943047
Pubmed

Dosage-dependent requirement for mouse Vezf1 in vascular system development.

DES ANGPT1 VEZF1

3.97e-062937315882861
Pubmed

Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.

CCDC88C DES ERC1 PIK3R1

5.98e-0611137422558309
Pubmed

CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.

CD36 GPC4

6.60e-06437231484922
Pubmed

Serum response factor is required for sprouting angiogenesis and vascular integrity.

DES ANGPT1 VEZF1

1.33e-054337318804439
Pubmed

Activation of rapid oestrogen signalling in aggressive human breast cancers.

NCOA3 PIK3R1

1.65e-05637223065768
Pubmed

The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.

DES ANGPT1

1.65e-05637221355089
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CCDC88C CCP110 PJA2 TRIP11 MYO9A ERC1 SH3D19

3.00e-0586137736931259
Pubmed

Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice.

DES ANGPT1

3.95e-05937215579434
Pubmed

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.

ZFHX3 ADCY3

3.95e-05937221042317
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

SCYL2 CCP110 NCOA3 KATNIP SMC3 TRIP11 ERC1 PIK3R1

6.13e-05132137827173435
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PJA2 KATNIP NFAT5 ERC1 ADCY3

6.86e-0540737512693553
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

CCDC88C CHD9 MYO9A PUF60

7.03e-0520837433230847
Pubmed

CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis.

DES ANGPT1

7.22e-051237222363445
Pubmed

Pathway analysis in HEK 293T cells overexpressing HIV-1 tat and nucleocapsid.

NCOA3 GPC4

8.53e-051337219884766
Pubmed

TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.

NCOA3 ZFHX3 SMC3 PUF60

8.73e-0522037435785414
Pubmed

The Notch target genes Hey1 and Hey2 are required for embryonic vascular development.

ANGPT1 VEZF1

1.15e-041537215107403
Pubmed

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

DES ANGPT1

1.15e-041537221606590
Pubmed

The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis.

ANGPT1 PIK3R1

1.48e-041737216107612
Pubmed

Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.

RNASE2 IL23R

1.48e-041737220570966
Pubmed

A human MAP kinase interactome.

DES SMC3 MYO9A PIK3R1 SH3D19

1.57e-0448637520936779
Pubmed

Chloride intracellular channel 4 is required for maturation of the cerebral collateral circulation.

DES ANGPT1

1.67e-041837226276819
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CCDC88C CCP110 MYO15B ANGPT1 SBF2

1.68e-0449337515368895
Pubmed

Proximity interactions among centrosome components identify regulators of centriole duplication.

CCP110 PJA2 MYO9A

1.72e-0410137324613305
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

NCOA3 ZFHX3 ZNF236 VEZF1 NFAT5 NR1D2

1.94e-0480837620412781
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

SCYL2 CHD9 SMC3 GPC4

2.26e-0428237423667531
Pubmed

Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels.

DES ANGPT1

2.75e-042337229237738
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

SCYL2 TRIP11 PUF60 ERC1 SH3D19

3.15e-0456537525468996
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SCYL2 CHD9 TRIP11 ERC1 PIK3R1 SH3D19 NR1D2

3.60e-04128537735914814
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

BDP1 CCP110 TRIP11 MYO9A ERC1

3.79e-0458837538580884
Pubmed

Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.

DES NCOA3

4.09e-042837224880616
Pubmed

Radial glial neural progenitors regulate nascent brain vascular network stabilization via inhibition of Wnt signaling.

DES ANGPT1

4.70e-043037223349620
Pubmed

Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier.

DES ANGPT1

6.05e-043437226120030
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

SCYL2 CCP110 NCOA3 PJA2 KATNIP SBF2

7.34e-04103837626673895
Pubmed

Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.

CD36 CD109

7.56e-043837216263699
Pubmed

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.

KPNA5 NCOA3

8.37e-044037228805822
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

SCYL2 SMC3 MYO9A ERC1 SH3D19

8.76e-0470837539231216
Pubmed

Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.

DES ANGPT1

9.23e-044237211439183
Pubmed

Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.

SCYL2 SMC3 PUF60 CD109

1.03e-0342237427342126
CoexpressionKANG_DOXORUBICIN_RESISTANCE_DN

NCOA3 NFAT5 NR1D2

2.47e-0619373M3323
CoexpressionAtlasMyeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2

NABP1 GBP5 NFAT5 MYO9A CD36 SBF2

5.42e-05403366GSM605834_500
CoexpressionAtlasMyeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3

NABP1 GBP5 NFAT5 MYO9A CD36 SBF2

6.63e-05418366GSM605836_500
ToppCellmild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

BDP1 GBP5 PIK3R1 IL23R NR1D2

6.25e-07199375cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

KPNA5 NABP1 ANGPT1 CD36

9.28e-061603740293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

KPNA5 NABP1 ANGPT1 CD36

9.28e-061603743eaae86fa08f7651021316f8e5811bf48055591e
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC88C GBP5 SMC3 TRIP11

1.41e-0517837401dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells)

CCDC88C GBP5 ADCY3 RALGPS1

1.44e-05179374c09c3eed43d1aa3b7aa8f3021e6f2737840cde16
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES CCP110 ADCY3 GPC4

1.57e-051833740e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES CCP110 ADCY3 GPC4

1.57e-05183374cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCellE17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DES ZFHX3 ADCY3 GPC4

1.71e-051873740dee138738b65531ff134a125b92234b5d0a653c
ToppCellP03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DES ZFHX3 ADCY3 GPC4

1.79e-05189374b5439ef221106f6d54434f268485e9bb17b39102
ToppCellfacs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES NR1D2 CD109 GPC4

1.82e-05190374c7bd087f36321cec61b98657433b4d19d135791f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES NR1D2 CD109 GPC4

1.82e-05190374834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 ANGPT1 GPC4

1.90e-05192374e5117cdb8af220f60bd1410262078c0306667b4a
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ERC1 CD36 SH3D19 SBF2

1.94e-05193374e1d546165dcc2392f540162206852c4717d7306f
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BDP1 TRIP11 ERC1 NR1D2

1.98e-05194374e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DES ZFHX3 ANGPT1 GPC4

2.02e-051953746e875c83f838241b5fcaf4a3249b1408d74521dc
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFHX3 RNASE2 CD36 CD109

2.06e-0519637480264c2fbd94418f981085fed7c5bdda1e6f404c
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 ANGPT1 GPC4

2.06e-05196374184104cbea0461dd2757668ab9755948ac7b585a
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 ANGPT1 GPC4

2.06e-05196374bebb20dc210576101c317011e3afb59798f5d255
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 ANGPT1 GPC4

2.06e-051963748114e98923096c54b6834f21550c3061bab6773d
ToppCell5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DES ZFHX3 ANGPT1 ADCY3

2.06e-05196374ce6f7ddb8104471dc90347f427486379914d63b4
ToppCell5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DES ZFHX3 ANGPT1 ADCY3

2.06e-051963746d7179decea512dd49bb2d5f6a4f5989349d52a9
ToppCellCOVID-19|World / Condition, Lineage and Cell class

CCDC88C RNASE2 GBP5 CD36

2.10e-05197374228f641d79282cc3dc51b95a1f4b0cccfc200735
ToppCellParenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

NUTM1 CCDC88C NABP1 GBP5

2.19e-051993745a29db2610ba06a2248325a16cad755d20debf2c
ToppCellcontrol-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CHD9 NFAT5 PIK3R1 CD36

2.19e-051993743d01f90ffd271ca00129192787e4921bdca7e01e
ToppCellLPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

DES ZFHX3 PIK3R1 GPC4

2.23e-0520037467dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DES ZFHX3 PIK3R1 GPC4

2.23e-05200374f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GBP5 IL23R SH3D19

2.45e-0414737348d72b6770cd029dd299676e5d83e6ac62102049
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFHX3 RNASE2 IL23R

2.50e-04148373fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0
ToppCellLPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZFHX3 ADCY3 GPC4

2.91e-041563736365b69ede98bc866e996bc52736b00401aacf6f
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac-Intermediate_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue

ZFHX3 RNASE2 CD109

3.43e-04165373c3fa9225d2f9c9e821d4fbd2315fcc98ce1f1c55
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZFHX3 RNASE2 CD109

3.75e-041703737bba77ae34a0259fad6ee98cf665ff50f77a1328
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DES ZFHX3 GPC4

3.75e-041703731f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZFHX3 RNASE2 CD109

3.75e-04170373a43b977a7fe745536cf96b7c080397d9fa73086b
ToppCellfacs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC88C NCOA3 ANGPT1

3.81e-04171373c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue

RNASE2 ANGPT1 CD36

3.81e-04171373098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPT1 GBP5 CD109

3.88e-041723733f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type

GBP5 PIK3R1 IL23R

3.88e-0417237318bda0038cb37da6784e7bf7291272c108cfd9c5
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

MYO15B ADCY3 IL23R

3.94e-04173373efb8072475000888efe088d00e870c56ffad4172
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DES ADCY3 GPC4

4.01e-04174373a7ade7372e83edd4e3983e77f8417b51f0b47340
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

RNASE2 ANGPT1 CD36

4.01e-0417437305d54a36772f096047521e16a89cc42ae48d2a1d
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MYO15B ADCY3 IL23R

4.01e-0417437358300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANGPT1 PIK3R1 GPC4

4.08e-041753731799a7be623dc3bf53ba580a7c47d2619969d708
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

KATNIP MYO15B RALGPS1

4.08e-0417537387e557f7508c88b2087db5d57e77d5e2c92ca083
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DES ZFHX3 ADCY3

4.08e-04175373316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DES ZFHX3 ADCY3

4.08e-04175373a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GBP5 PIK3R1 IL23R

4.08e-04175373cc2428150987911d0d382e8177918724aa69f85c
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 TRIP11 MYO9A

4.15e-04176373749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GBP5 PIK3R1 IL23R

4.15e-04176373003076f1a983409ddf31b9c19e61c1facdd72566
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPT1 MYO9A CD109

4.15e-041763735e46a09a36b9645b1b1fcb0b64bd0898561af3a9
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANGPT1 MYO9A SH3D19

4.22e-04177373b7fee75de7e96924af488a5baa2334711889ae7c
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPT1 MYO9A CD109

4.22e-0417737314fb8d182775dfd0e49aa7e4e12543a85b3b8bd6
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GBP5 PIK3R1 IL23R

4.22e-04177373605f71515c877bb4de4121675ec8c1318a2500a7
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

NCOA3 NFAT5 IL23R

4.22e-0417737382fdd6185b368f54f03de389427cbe3071d21a99
ToppCellIIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type

GBP5 PIK3R1 IL23R

4.29e-04178373be777ebef8f09a1a16fcee8fc69a65ab295b6e1d
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

NABP1 GBP5 PIK3R1

4.29e-0417837390dedb3cef9b01907b9f8eec64218d6d2072be1f
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

NABP1 GBP5 PIK3R1

4.29e-04178373d6312286bf6cc5b107ccd7adb583d9667d4e1d21
ToppCelldroplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ANGPT1 GPC4

4.36e-04179373bfc226bcf0b93525992344f968268a261d86fcbf
ToppCelldroplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ANGPT1 GPC4

4.36e-0417937336ad18f52e175ab636ceaa3be81212fa362c96c1
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DES ANGPT1 GPC4

4.36e-0417937356db12467b445f2b8ef92af50779eeab10413eb2
ToppCellLA-01._Fibroblast_I|LA / Chamber and Cluster_Paper

CHD9 ZFHX3 SH3D19

4.36e-04179373dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCP110 KATNIP CROCC2

4.43e-0418037392fb01b91261b3103454924cde56add337b41844
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GBP5 PIK3R1 IL23R

4.43e-041803731c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GBP5 PIK3R1 IL23R

4.43e-04180373e53e9f3ebd48fb8237515e740ba5d9880ed6ade3
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GBP5 PIK3R1 IL23R

4.43e-04180373ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

DES ZFHX3 ANGPT1

4.43e-04180373d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GBP5 PIK3R1 IL23R

4.43e-041803730a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCellnormal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

GBP5 PIK3R1 IL23R

4.43e-04180373e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GBP5 PIK3R1 IL23R

4.43e-041803739d18aa1044945fe6481ea3284037a777657fd837
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells)

ZNF236 GBP5 IL23R

4.43e-04180373551b8de8d933d11bcd3897aeb2fd033355f958e2
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NFAT5 MYO9A GPC4

4.50e-041813736a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCelldroplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 ANGPT1 TRIP11

4.57e-041823731710eab3037a87609d21838be2d2d29c3bc36651
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DES ZFHX3 ANGPT1

4.57e-041823731c1a687f728341c209b048b6715bcddd0ac20069
ToppCellPericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

DES ZFHX3 ANGPT1

4.57e-0418237346c213597445b1f4f09dc367f27702d24b201daf
ToppCelldroplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 ANGPT1 TRIP11

4.57e-04182373e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DES ZFHX3 ANGPT1

4.57e-0418237397bb07478f56a937b490fba121ee603db64134a1
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 CD109

4.57e-04182373ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PUF60 ADCY3 SH3D19

4.65e-04183373ba7753e9fe2a6a87c5264f299ac97da2ddbda178
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NABP1 ADCY3 CD109

4.65e-04183373ff751a97466807bf04b5a0740138c61e298cd1fc
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

CCDC88C DES ZFHX3

4.65e-04183373e84539978ab4de42e19186aed00f24bb50cbc21f
ToppCelldroplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DES ANGPT1 GPC4

4.72e-041843737128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCelldroplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DES ANGPT1 GPC4

4.72e-04184373d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZFHX3 ADCY3 GPC4

4.72e-04184373689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NFAT5 MYO9A GPC4

4.72e-04184373da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCellP28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DES ANGPT1 GPC4

4.72e-0418437323c24ab5786af33d605bc445d06117b9da6c6331
ToppCelldroplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DES ANGPT1 GPC4

4.72e-0418437355dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells)

GBP5 PIK3R1 SBF2

4.72e-041843735b4f18b26d03e8e5798cac70d124534749fc4cc0
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DES ANGPT1 GPC4

4.72e-0418437339bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RNASE2 MYO15B CD36

4.72e-04184373bc0dfe29337f02594e7e0092c9e47dda94b45ad5
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DES ANGPT1 GPC4

4.72e-041843734cb5f299dd7413e0be1ad7af817ee614b23a18ae
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZFHX3 ADCY3 GPC4

4.72e-04184373327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANGPT1 ADCY3 CD36

4.79e-041853737092436b4db90289516ed130ade596e3021cffaf
ToppCellControl-Lymphocyte-T_NK-CD4_TEM|Control / Disease, Lineage and Cell Type

GBP5 PIK3R1 IL23R

4.79e-041853738d6a089dcb4bfb0e74b6316fb7221688c1835e6e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 ANGPT1 ADCY3

4.79e-0418537351dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 VEZF1

4.79e-0418537338486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCellP15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DES ANGPT1 GPC4

4.79e-04185373b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 ANGPT1 ADCY3

4.79e-04185373a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES ZFHX3 VEZF1

4.79e-041853733c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANGPT1 ADCY3 CD36

4.79e-04185373a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCellHealthy-MAIT|Healthy / disease group, cell group and cell class

NUTM1 GBP5 IL23R

4.87e-04186373028061f06d86e75cb06db56b199594b80f23fa58
ToppCelldroplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DES CD109 GPC4

4.87e-04186373cd6502bbf9dce318fdbb4965d49df8951e5f795c
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

SCYL2 NCOA3 CHD9 SMC3 PIK3R1

1.12e-051833757498_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

NFAT5 SMC3 ERC1 PIK3R1 NR1D2

1.18e-051853751673_DN
DrugEtidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A

ZFHX3 MYO9A ERC1 ADCY3 PIK3R1

1.28e-051883753325_DN
DrugPregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A

NFAT5 TRIP11 ADCY3 RALGPS1 GPC4

1.57e-051963752856_DN
Drugtestosterone enanthate

NCOA3 ANGPT1 NFAT5 SMC3 MYO9A ERC1 ADCY3

3.37e-05575377ctd:C004648
DrugIAHS

SMC3 CD36

9.18e-059372CID003037832
DrugSuccimer

PJA2 CHD9 NABP1 NFAT5 TRIP11 PIK3R1 CD36 NR1D2 CD109

1.47e-041264379ctd:D004113
DrugMagnetite Nanoparticles

PJA2 CHD9 NABP1 NFAT5 TRIP11 PIK3R1 CD36 NR1D2 CD109

1.93e-041310379ctd:D058185
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

SCYL2 NFAT5 SMC3 NR1D2

1.95e-041783743998_DN
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A

NCOA3 NFAT5 SMC3 NR1D2

1.99e-041793744585_DN
Drugtorcetrapib

NCOA3 CHD9 ANGPT1 SMC3 ERC1

2.18e-04342375ctd:C483909
Drugmyxothiazol

NFAT5 CD36

2.31e-0414372ctd:C030517
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

SCYL2 NCOA3 NFAT5 SMC3

2.40e-041883746735_DN
DrugChlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A

SCYL2 KPNA5 NFAT5 PIK3R1

2.45e-041893743788_DN
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A

CCP110 NFAT5 SMC3 NR1D2

2.50e-041903744306_DN
DrugBudesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

SCYL2 SMC3 PIK3R1 NR1D2

2.50e-041903742866_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

NFAT5 SMC3 PIK3R1 NR1D2

2.55e-041913744303_DN
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

NABP1 NFAT5 RALGPS1 NR1D2

2.55e-041913744279_DN
DrugProguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A

KATNIP TRIP11 RALGPS1 GPC4

2.60e-041923743505_DN
DrugCarbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A

SCYL2 NFAT5 ADCY3 RALGPS1

2.71e-041943741805_UP
Drug5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA

ZFHX3 NFAT5 PIK3R1 RALGPS1

2.76e-04195374843_DN
DrugPropylthiouracil [51-52-5]; Down 200; 23.4uM; HL60; HT_HG-U133A

SCYL2 NFAT5 TRIP11 PIK3R1

2.82e-041963742476_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A

NFAT5 TRIP11 PIK3R1 RALGPS1

2.82e-041963744689_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A

PJA2 NFAT5 ERC1 NR1D2

2.82e-041963741794_DN
Drugestradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A

CCDC88C NFAT5 PIK3R1 CD36

2.82e-041963741182_DN
DrugBenzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A

KPNA5 CCDC88C NCOA3 TRIP11

2.82e-041963741801_UP
DrugChelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A

CCDC88C CHD9 ADCY3 GPC4

2.82e-041963746236_DN
DrugThalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A

NFAT5 SMC3 PIK3R1 RALGPS1

2.82e-041963742258_DN
DrugPNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A

SCYL2 KPNA5 CCP110 RALGPS1

2.82e-041963746568_UP
Drug2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A

KPNA5 RALGPS1 CD36 GPC4

2.82e-041963746934_UP
Drugwartmannin

ANGPT1 VEZF1 NFAT5 MYO9A PIK3R1 CD36 SBF2

2.87e-04811377CID000005691
DrugHydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A

SCYL2 ZFHX3 NABP1 SMC3

2.87e-041973742119_UP
DrugDNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A

NABP1 NFAT5 TRIP11 ERC1

2.87e-041973747543_DN
DrugThalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A

SCYL2 KATNIP NFAT5 GPC4

2.87e-041973742095_DN
DrugIvermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A

NFAT5 ERC1 RALGPS1 GPC4

2.87e-041973747206_DN
DrugIsoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A

DES ZNF236 NFAT5 RALGPS1

2.87e-041973741485_UP
DrugGentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A

SCYL2 NCOA3 NFAT5 PIK3R1

2.87e-041973742082_DN
DrugSulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; HL60; HT_HG-U133A

SCYL2 NCOA3 NFAT5 PIK3R1

2.93e-041983742560_DN
Drugclozapine; Down 200; 10uM; HL60; HT_HG-U133A

NCOA3 KATNIP ZNF236 CD36

2.93e-041983741170_DN
DrugDantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A

ANGPT1 ZNF236 NFAT5 PIK3R1

2.93e-041983744343_UP
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A

CCDC88C ZNF236 PIK3R1 CD36

2.93e-041983741184_DN
DrugPHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A

DES ANGPT1 NFAT5 PIK3R1

2.93e-041983744333_UP
Drug(-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; HL60; HG-U133A

CCDC88C NCOA3 ZNF236 MYO9A

2.98e-041993741780_UP
Drug0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A

ANGPT1 ZNF236 NFAT5 PIK3R1

2.98e-041993744334_UP
DrugMoxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; HL60; HT_HG-U133A

ZNF236 NFAT5 ADCY3 PIK3R1

3.04e-042003741846_UP
Druggeldanamycin

SCYL2 BDP1 ANGPT1 NFAT5 PIK3R1

3.17e-04371375ctd:C001277
DiseaseAntihypertensive use measurement

NFAT5 ADCY3 PIK3R1 RALGPS1 SBF2

1.94e-05265375EFO_0009927
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

ZFHX3 NFAT5 ADCY3 PIK3R1 RALGPS1

8.76e-05364375EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Diseasevital capacity

NCOA3 ZFHX3 NFAT5 TRIP11 ERC1 ADCY3 PIK3R1 CROCC2

1.21e-041236378EFO_0004312
Diseasebody fat percentage

ZFHX3 NFAT5 ADCY3 PIK3R1 RALGPS1

3.41e-04488375EFO_0007800
Diseasenephrosis (biomarker_via_orthology)

ANGPT1 CD36

3.48e-0422372DOID:2527 (biomarker_via_orthology)
DiseaseGrey matter density measurement

KATNIP NABP1

8.37e-0434372EFO_0010306

Protein segments in the cluster

PeptideGeneStartEntry
METIVMQENNEQTDT

BDP1

1471

A6H8Y1
ENMKSEMAQIQQNAV

ANGPT1

106

Q15389
TDMVQMIFSNNADQQ

KPNA5

86

O15131
ENQHMQMTIQALQDE

ERC1

221

Q8IUD2
GSIMENEQRSNQMNN

RALGPS1

221

Q5JS13
ITMQNQLQQNMQEGL

SBF2

956

Q86WG5
DAIMNMQDNSVQVSQ

GPC4

321

O75487
SNQAEDQDVQMMNEN

KATNIP

1571

O60303
DQDVQMMNENQIITN

KATNIP

1576

O60303
SQQNQMLLEQNMENK

CCDC88C

1346

Q9P219
QKMQEQQMQEQAAQL

GBP5

541

Q96PP8
TVANNGMNNNMSLQD

PIK3R1

316

P27986
QQQQQQQQVMESSAA

NFAT5

881

O94916
MSALQTSINQQDMQQ

NFAT5

1381

O94916
AEEMQIQNTQLMNGS

NUTM1

291

Q86Y26
MSLSLEQQMQQRQQQ

MYO15B

896

Q96JP2
MTNASNSQQSISMQQ

CHD9

216

Q3L8U1
VNLMNASNDITMENV

CD109

596

Q6YHK3
QNQQLQAQMTEMEQA

CROCC2

1556

H7BZ55
QNPQEVMMNSSNIQV

CD36

71

P16671
QAQLQEQQVQVEMDM

DES

251

P17661
MLQENSELMNNNSSE

IL23R

411

Q5VWK5
MNLEEQSQQQENLML

ADCY3

266

O60266
QNQNTRQQMDTPMVS

CCP110

556

O43303
MYNQEQQENSAESMQ

NR1D2

266

Q14995
GAQSEQKNNSMNSNM

NABP1

126

Q96AH0
IDQLMNQMQQIETQQ

SMC3

711

Q9UQE7
QQQQLTNLQMAAVTM

PUF60

91

Q9UHX1
MNIMNTEQSQNSIVS

SH3D19

1

Q5HYK7
QSPSFNSMMNQMNQQ

NCOA3

1131

Q9Y6Q9
MQEQQKSLDIGNQMN

SCYL2

616

Q6P3W7
QHINMTSQQCTNAMQ

RNASE2

41

P10153
TCMSEETSNQKQQQQ

VEZF1

326

Q14119
QQVMTTVQNMQHESA

TRIP11

1226

Q15643
DQQSMQASTQMQVEI

ZNF236

786

Q9UL36
QMIMENQNSENTAQV

SPZ1

191

Q9BXG8
QDEMVSTKQQNNTSQ

PJA2

261

O43164
NMMLLQQNMTQIQHN

ZFHX3

831

Q15911
QQNEKEMMEQIRQQT

MYO9A

1506

B2RTY4
AMETDITEQQQAAMQ

MYO9A

2316

B2RTY4